LXRX

Lexicon Pharmaceuticals, Inc. Press Releases

$1.38
*  
0.01
0.73%
Get LXRX Alerts
*Delayed - data as of Oct. 24, 2014 12:48 ET  -  Find a broker to begin trading LXRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LXRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate
10/22/2014 1:01:00 AM - PR Newswire
▲3.76 % Price Change since this news event. The Volume Ratio is 0.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Nurix, Inc. Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer
9/18/2014 8:25:00 AM - Business Wire


Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care
9/11/2014 4:30:00 PM - PR Newswire


Lexicon To Present At The Morgan Stanley 2014 Global Healthcare Conference
9/4/2014 7:00:00 AM - PR Newswire


Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference
8/8/2014 8:00:00 AM - PR Newswire


Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results
8/7/2014 7:00:00 AM - PR Newswire


Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014
8/5/2014 7:00:00 AM - PR Newswire